Microvision, INC

Market Movers (8-K)

See all →
NASDAQ
MicroVision, Inc. announced the pricing of its public offering of 6.8 million units, each consisting of one share of common stock and one warrant, raising approximately $17.0 million.
Capital raise
NASDAQ
MicroVision, Inc. announced the appointment of Christine Chambers as its new Chief Financial Officer, effective August 27, 2026, bringing extensive financial leadership experience to the company.
NASDAQ
MicroVision, Inc. is implementing a 1-for-15 reverse stock split to maintain its Nasdaq listing and support its growth strategy.
NASDAQ
MicroVision, Inc. held its annual shareholder meeting on July 10, 2026, with key votes on director elections, a potential reverse stock split, and auditor ratification.
Capital raise
NASDAQ
MicroVision, Inc. published a CEO Letter and Q&A to clarify topics following its June 25th business update and shareholder event.
NASDAQ
MicroVision, Inc. published presentation slides in connection with its June 25, 2026, virtual Business Update and Shareholder Q&A event.

Quarterly Earnings (10-Q)

See all →
NASDAQ
MicroVision reports Q1 2026 results, highlighting strategic acquisitions of lidar assets and ongoing efforts to reduce operating expenses.
Capital raise
NASDAQ
MicroVision reported a narrower net loss in Q3 2025 and for the nine-month period, driven by reduced operating expenses, while announcing a strategic acquisition of 1550nm FMCW LiDAR technology.
Capital raise
NASDAQ
MicroVision, Inc. reported a reduced net loss for Q2 2025 and the first half of 2025, driven by significant operating expense cuts, despite a sharp decline in revenue.
Worse than expected
Capital raise
NASDAQ
MicroVision's Q1 2025 results show a revenue decrease compared to the previous year, with the company continuing to focus on its lidar and AI technology for automotive and industrial applications.
Worse than expected
Capital raise
NASDAQ
MicroVision's Q3 2024 results show a decrease in revenue compared to the previous year, alongside significant restructuring efforts and a new convertible note issuance.
Worse than expected
Delay expected
Capital raise
NASDAQ
MicroVision's Q2 2024 results show a significant increase in revenue compared to the previous year, alongside a restructuring effort to focus on core lidar technologies.
Worse than expected
Capital raise

Annual Reports (10-K)

NASDAQ
MicroVision, Inc. filed an amendment to its 2025 Annual Report to provide required Part III disclosures regarding executive compensation and corporate governance.
Delay expected
NASDAQ
MicroVision reported a significant revenue decline and substantial net losses for 2025, alongside strategic acquisitions and ongoing capital raises, while facing a Nasdaq minimum bid price compliance issue.
Worse than expected
Capital raise
NASDAQ
MicroVision's FY2024 results reveal ongoing losses as the company focuses on its lidar sensors and perception software for industrial, automotive, and military markets.
Capital raise
Worse than expected
NASDAQ
MicroVision's 2023 annual report highlights a strategic pivot towards automotive lidar solutions, marked by the acquisition of Ibeo assets and a significant increase in operating expenses.
Worse than expected
Capital raise

Insider Trading (Form 4)

See all →
NASDAQ
Jada Smith, a Director of Microvision, Inc., received 280,152 shares of common stock on July 16, 2026.
NASDAQ
Peter Schabert, a Director of Microvision, Inc., received 280,152 shares of common stock on July 16, 2026.
NASDAQ
Laura J. Peterson, a Director of Microvision, Inc., received 280,152 shares of common stock on July 16, 2026.
NASDAQ
Jeffrey A Herbst, a Director of Microvision, Inc., received 280,152 shares of common stock on July 16, 2026.
NASDAQ
Robert Paul Carlile, a Director of Microvision, Inc., received 280,152 shares of common stock on July 16, 2026.
NASDAQ
MicroVision CEO Glen W. DeVos disposed of 183,233 shares to cover tax withholding obligations related to equity awards.

Proxy Statements (Def-14A)

NASDAQ
MicroVision is holding its 2026 Annual Meeting of Shareholders to vote on key proposals, including a reverse stock split and the issuance of shares for convertible notes, aimed at improving stock price and financial flexibility.
Capital raise
NASDAQ
MicroVision, Inc. has filed a supplement to its proxy statement to inform shareholders of the merger between its independent auditor, Moss Adams LLP, and Baker Tilly US, LLP, resulting in Baker Tilly's appointment as the new auditor.
NASDAQ
MicroVision, Inc. is strongly urging shareholders to vote 'FOR' Proposal Two, which seeks to increase the number of authorized shares of common stock, emphasizing its critical importance for executing the company's strategic plan and demonstrating financial strength.
Capital raise
NASDAQ
MicroVision is asking shareholders to approve an increase in authorized shares of common stock and an amendment to the 2022 Equity Incentive Plan at the upcoming annual meeting.
Capital raise
Worse than expected
NASDAQ
MicroVision's 2024 Annual Meeting of Shareholders will be held virtually on June 5, 2024, to vote on director elections, executive compensation, and the ratification of the company's accounting firm.

Schedule 13G - Passive Investments

NASDAQ
The Vanguard Group has filed an amended Schedule 13G for MicroVision Inc., reporting 0% beneficial ownership following an internal realignment that disaggregates reporting to its subsidiaries.
NASDAQ
State Street Corporation has reported a 4.5% beneficial ownership stake in MicroVision Inc., holding over 13.4 million shares.
NASDAQ
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 5.8% beneficial ownership stake in MicroVision, Inc. common stock.
NASDAQ
State Street Corporation has disclosed a 5.2% beneficial ownership stake in MicroVision Inc.'s common stock, totaling over 13 million shares.